Skip to content

Laser Versus Ultrasonic Lithotripsy in Percutaneous Nephrolithotomy for Staghorn Stones

Laser Versus Ultrasonic Lithotripsy in Percutaneous Nephrolithotomy for Staghorn Stones

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01922414
Enrollment
70
Registered
2013-08-14
Start date
2011-08-31
Completion date
2014-09-30
Last updated
2015-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stones

Keywords

Staghorn stones, Percutaneous nephrolithotomy, Laser, Randomized trial, Lithotripsy

Brief summary

This study will be conducted to compare the results of Laser and ultrasonic lithotripsy in disintegration of staghorn stones during percutaneous nephrolithotomy.

Detailed description

Patients with complete staghorn stones who are eligible to percutaneous nephrolithotomy (PNL) will be randomized between two groups. Group 1: will undergo Laser lithotripsy during PNL Group 2: will undergo ultrasonic lithotripsy during PNL

Interventions

DEVICELaser

Patients will undergo laser lithotripsy durin PNL

Patients will undergo ultrasonic lithotripsy during PNL

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Complete staghorn stones (filling the renal pelvis and branching to 3 major calyces 2. Age: 18-70 years

Exclusion criteria

1. Congenital renal anomalies such as horse shoe kidney. 2. Contraindications to PNL such as bleeding tendency and uncontrolled hypertension. 3. Associated pathological features requiring open intervention such as UPJO 4. Partial staghorn stones (filling the renal pelvis and branching to 2 major calyces) 5. Giant staghorn stone (very large staghorn stone that branch and re-branch in hugely dilated calyceal system)

Design outcomes

Primary

MeasureTime frameDescription
Stone Free ratePatients will be followed for 3 months after the procedureAssessment of stone free rate after 3 months from treatment using NCCT

Secondary

MeasureTime frameDescription
Assessment of the safety of each techniqueFrom the start of the operation till 3 months after discharge from the hospitalMeasurement of complication rates, classifications of the severity of complications
Operative timeAn expected average of 3 hoursMeasurement of the time from start of ureteral catheter fixation till the fixation of the nephrostomy tube
Hospital stayup to 7 days

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026